Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 03:59:03 UTC
Update Date2021-09-26 23:00:23 UTC
HMDB IDHMDB0249471
Secondary Accession NumbersNone
Metabolite Identification
Common NameButriptyline
DescriptionButriptyline, also known as evadyne, belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring. Butriptyline is a very strong basic compound (based on its pKa). It is the isobutyl side chain homologue of amitriptyline. Butriptyline is a tricyclic antidepressant which has been used in Europe since 1974. Gastrointestinal disturbances (including nausea and vomiting), drowsiness, tremor, low blood pressure when standing, dizziness, sweating, weakness and fatigue, incoordination, epilepsy-like seizures, and speech difficulties may occur. Side effects of tricyclic antidepressants include dry mouth, sour or metallic taste, constipation, retention of urine, blurred vision and changes in focusing, palpitations, and fast heart beat. This compound has been identified in human blood as reported by (PMID: 31557052 ). Butriptyline is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Butriptyline is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
EvadyneKegg
Butriptyline hydrochloride, (+-)-isomerMeSH
10,11-Dihydro-N,N,beta-trimethyl-5H-dibenzo(a,D) cycloheptane-5-propylamineMeSH
Butriptyline, (+-)-isomerMeSH
Butriptyline hydrochlorideMeSH
ButriptyleneMeSH
Chemical FormulaC21H27N
Average Molecular Weight293.4458
Monoisotopic Molecular Weight293.214349869
IUPAC Namedimethyl(2-methyl-3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)amine
Traditional Namebutriptyline
CAS Registry NumberNot Available
SMILES
CC(CC1C2=CC=CC=C2CCC2=CC=CC=C12)CN(C)C
InChI Identifier
InChI=1S/C21H27N/c1-16(15-22(2)3)14-21-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)21/h4-11,16,21H,12-15H2,1-3H3
InChI KeyALELTFCQZDXAMQ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassDibenzocycloheptenes
Sub ClassNot Available
Direct ParentDibenzocycloheptenes
Alternative Parents
Substituents
  • Dibenzocycloheptene
  • Aralkylamine
  • Tertiary aliphatic amine
  • Tertiary amine
  • Organic nitrogen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Amine
  • Aromatic homopolycyclic compound
Molecular FrameworkAromatic homopolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP5.44ChemAxon
pKa (Strongest Basic)10.01ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area3.24 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity95.95 m³·mol⁻¹ChemAxon
Polarizability35.53 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-197.27530932474
DeepCCS[M+Na]+172.6130932474
AllCCS[M+H]+172.732859911
AllCCS[M+H-H2O]+169.432859911
AllCCS[M+NH4]+175.832859911
AllCCS[M+Na]+176.732859911
AllCCS[M-H]-182.032859911
AllCCS[M+Na-2H]-181.832859911
AllCCS[M+HCOO]-181.832859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
ButriptylineCC(CC1C2=CC=CC=C2CCC2=CC=CC=C12)CN(C)C2869.9Standard polar33892256
ButriptylineCC(CC1C2=CC=CC=C2CCC2=CC=CC=C12)CN(C)C2205.6Standard non polar33892256
ButriptylineCC(CC1C2=CC=CC=C2CCC2=CC=CC=C12)CN(C)C2171.5Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Butriptyline GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-9340000000-599e7b771be6e4c672d42021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Butriptyline GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 10V, Positive-QTOFsplash10-0006-0090000000-fcdc735cf1f6f87d021f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 20V, Positive-QTOFsplash10-0005-1390000000-7e2f47992612fac4fda62016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 40V, Positive-QTOFsplash10-0006-7960000000-581cf9f5866770d253262016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 10V, Negative-QTOFsplash10-0006-0090000000-493334f63085dc31849f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 20V, Negative-QTOFsplash10-0006-0090000000-75fc4df499d36855eb2c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 40V, Negative-QTOFsplash10-0006-9560000000-d618a0d44ddb3dfbc2532016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 10V, Positive-QTOFsplash10-0006-0190000000-d68da30bb5c28850f9ca2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 20V, Positive-QTOFsplash10-0a4l-3390000000-3f62baa1e777aadc82332021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 40V, Positive-QTOFsplash10-0a4i-7890000000-e90be0872eba21ea457f2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 10V, Negative-QTOFsplash10-0006-0090000000-25264659bc9fd0f2879e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 20V, Negative-QTOFsplash10-0006-0190000000-f902aa459e092b5180482021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Butriptyline 40V, Negative-QTOFsplash10-0690-2290000000-06974eaa1a0edad3039d2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB09016
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkButriptyline
METLIN IDNot Available
PubChem Compound21772
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]